针对ADAM17抑制树突细胞介导的2型免疫反应和与过敏喘相关的呼吸道炎症
Anil Kumar Jaiswal1, Dmitriy Minond2, Amarjit Mishra3
1BioLegend, SanDiego, CA, USA.
Scientific reports
|August 25, 2025
概括
在过敏性喘中,ADAM17 (一种分解蛋白和金属蛋白酶域17) 起着关键作用. 在树突细胞中抑制ADAM17减少了呼吸道炎症,并保护小鼠免受喘症状的影响.
科学领域:
- 免疫学
- 对过敏的研究
- 基质金属蛋白酶
背景情况:
- ADAM17 (一种分解蛋白和金属蛋白酶域17) 是一种含的调节生物过程的酶.
- 由于ADAM17具有广泛的基质特征,它会影响炎症和适应性免疫.
- ADAM17在2型过敏喘发病过程中的特定作用在很大程度上尚未被研究.
研究的目的:
- 研究ADAM17在室内灰尘 (HDM) 引起的呼吸道炎症和适应性免疫反应中的作用.
- 评估树突细胞特异性ADAM17缺失 (ΔDC) 对过敏喘的影响.
- 在小鼠模型中评估新型小分子ADAM17抑制剂 (2155-17) 的疗效.
主要方法:
- 产生树突细胞特异性ADAM17缺乏的小鼠 (ΔDC).
- 使用室内灰尘 (HDM) 诱导过敏呼吸道炎症.
- 使用一种新的小分子ADAM17抑制剂 (2155-17).
- 对呼吸道过敏反应 (AHR) 的评估,对乙酸性偏振和免疫细胞功能的评估.
主要成果:
- 干细胞特异性ADAM17剥离 (ΔDC) 显著抑制了2型/异性过敏反应,并对AHR进行了保护.
- 缺少ADAM17的树突细胞表现出降低的新陈代谢活动,免疫启动受损,并抑制了过敏原特异性2型细胞分化.
- 在野生型小鼠中,ADAM17抑制剂2155-17的鼻内注射使其免受2型/eosinophilic HDM诱导的过敏反应的影响.
结论:
- 在2型过敏喘中,ADAM17起着关键的上游作用.
- 用选择性小分子抑制剂向ADAM17为2型高过敏喘提供了潜在的治疗策略.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
01:19Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:17Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
380
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
380
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K